Comparative performance of two methods that assess the quality of international normalized ratio measures

被引:1
|
作者
Shermock, Kenneth M. [1 ]
Tandon, Sangeeta [2 ]
Sorgen, Patrick J. [3 ]
Lavallee, Danielle C. [4 ]
Clarke, William [5 ]
Streiff, Michael B. [6 ]
机构
[1] Johns Hopkins Med Inst, Ctr Pharmaceut Outcomes, Baltimore, MD 21205 USA
[2] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA
[3] Purdue Univ, Coll Pharm, W Lafayette, IN 47907 USA
[4] Ctr Med Technol Policy, Baltimore, MD USA
[5] Johns Hopkins Sch Med, Dept Pathol, Div Clin Chem, Baltimore, MD USA
[6] Johns Hopkins Sch Med, Div Hematol, Dept Med, Baltimore, MD USA
关键词
Coagulation monitoring; Point-of-care testing; POCT; PT INR; Healthcare quality assurance; AGREEMENT;
D O I
10.1016/j.clinbiochem.2012.01.032
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: Two methods, Petersen's error grid analysis and Shermock's method to detect clinically important differences, were recently developed to advance the assessment of analytic performance of point-of-care INR devices. Both methods predict when alternate INR measures lead to different clinical decisions. Our goal was to compare their performance characteristics. Design and methods: Performance characteristics were assessed by comparing the models' predictions to clinical decisions that were directly measured in a previous experiment. Results: Shermock's method (82% of predictions correct) demonstrated superior predictive performance compared with the error grid analysis (75% of predictions correct, p = 0.008). Shermock's method was particularly superior at identifying the clinical decisions that actually disagreed (79% for Shermock's method vs. 47% for error grid). Consequently, Shermock's method was superior at identifying a POC device with poor performance (79% accuracy vs. 70%, p = 0.006). Conclusion: Shermock's method had superior performance characteristics and should be integrated into analytic strategies to assess POC INR devices. (C) 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:530 / 534
页数:5
相关论文
共 50 条
  • [1] THE CLINICAL IMPACT OF DIFFERENCES BETWEEN TWO MEASURES OF THE INTERNATIONAL NORMALIZED RATIO (INR)
    Shermock, K. M.
    Pinto, B. L.
    Streiff, M.
    VALUE IN HEALTH, 2009, 12 (03) : A145 - A145
  • [2] Extent of clinically important differences between two measures of the international normalized ratio (INR)
    Shermock, K. M.
    Pinto, B. L.
    Kraus, P. S.
    Streiff, M. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 293 - 293
  • [3] Interference of lupus anticoagulant causing antiprothrombin and anti -beta-2-glycoprotein I antibodies on international normalized ratio measurements: comparative analysis of international normalized ratio methods
    Gehlen, Rachel
    Moesbergen, Roxanne G.
    Bai, Cuicui
    de Groot, Philip G.
    Jansen, A. J. Gerard
    Meijers, Joost C. M.
    de Laat, Bas
    Remijn, Jasper A.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (05)
  • [4] Meta-Analysis to Assess the Quality of International Normalized Ratio Control and Associated Outcomes in Venous Thromboembolism Patients
    Chitsike, R. S.
    Kahn, S. R.
    Rodger, M. A.
    THROMBOSIS RESEARCH, 2014, 134 (06) : 1358 - 1358
  • [5] Meta-Analysis to Assess the Quality of International Normalized Ratio Control and Associated Outcomes in Venous Thromboembolism Patients
    Mearns, Elizabeth S.
    Kohn, Christine G.
    Song, Ju-Sung
    Hawthorne, Jessica
    Meng, Joy
    White, C. Michael
    Raut, Monika K.
    Schein, Jeff R.
    Coleman, Craig I.
    THROMBOSIS RESEARCH, 2014, 134 (02) : 310 - 319
  • [6] Validity of criteria used to evaluate fingerstick devices that assess international normalized ratio
    Shermock, Kenneth M.
    Connor, Jason T.
    Smith, Nicole T.
    Fink, Jodie M.
    Bragg, Lee
    MEDICAL DECISION MAKING, 2006, 26 (03) : 239 - 246
  • [7] NOVEL QUALITY ASSURANCE ANALYSIS REVEALS PREVIOUSLY UNDETECTED DEFICIENCIES IN A POINT OF CARE DEVICE THAT MEASURES THE INTERNATIONAL NORMALIZED RATIO
    Shermock, K. M.
    Pinto, B. L.
    Streiff, M. B.
    Lavallee, D. M.
    VALUE IN HEALTH, 2010, 13 (03) : A177 - A178
  • [8] Quality indicators for critical international normalized ratio measurements in a hemostatic laboratory
    Hussain, Shabneez
    Moiz, Bushra
    Afaqb, Bushra
    CLINICAL BIOCHEMISTRY, 2015, 48 (7-8) : 483 - 488
  • [9] International Normalized Ratio Variability: A Measure of Anticoagulation Quality or a Powerful Mortality Predictor
    Vanerio, Gabriel
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (10): : 2223 - 2228
  • [10] Comparison of the Abilities of Summary Measures of International Normalized Ratio Control to Predict Clinically Relevant Bleeding
    Rose, Adam J.
    Delate, Thomas
    Ozonoff, Al
    Witt, Daniel M.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2015, 8 (05): : 524 - 531